No abstract available
MeSH terms
-
Adjuvants, Immunologic*
-
Analysis of Variance
-
BCG Vaccine*
-
Carcinoma in Situ / therapy
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
-
Logistic Models
-
Odds Ratio
-
Risk Factors
-
Urinary Bladder Neoplasms / therapy*
Substances
-
Adjuvants, Immunologic
-
BCG Vaccine
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors